Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAmortizatization of IntangiblesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in IntangiblesDepreciation & Amortization (CF)Free Cash FlowGains from Investment SecuritiesLong-Term Debt RepaymentsNet Cash FlowNet IncomeOther Working Capital ChangesSales of Property, Plant and EquipmentShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Core Scientific (CORZ) Cash from Operations (2021 - 2025)

Core Scientific's Cash from Operations history spans 5 years, with the latest figure at 157510000.0 for Q4 2025.

  • For Q4 2025, Cash from Operations rose 1040.96% year-over-year to 157510000.0; the TTM value through Dec 2025 reached 278250000.0, up 548.66%, while the annual FY2025 figure was 278250000.0, 548.66% up from the prior year.
  • Cash from Operations for Q4 2025 was 157510000.0 at Core Scientific, up from 131781000.0 in the prior quarter.
  • Across five years, Cash from Operations topped out at 157510000.0 in Q4 2025 and bottomed at 136743000.0 in Q2 2021.
  • The 5-year median for Cash from Operations is 16723500.0 (2021), against an average of 26735600.0.
  • The largest YoY upside for Cash from Operations was 2723.92% in 2025 against a maximum downside of 303.13% in 2025.
  • A 5-year view of Cash from Operations shows it stood at 109739000.0 in 2021, then grew by 5.72% to 116014000.0 in 2022, then crashed by 81.29% to 21703000.0 in 2023, then crashed by 36.39% to 13805000.0 in 2024, then skyrocketed by 1040.96% to 157510000.0 in 2025.
  • Per Business Quant, the three most recent readings for CORZ's Cash from Operations are 157510000.0 (Q4 2025), 131781000.0 (Q3 2025), and 34000000.0 (Q2 2025).